USPTO serial 78457903
AXOSINE
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- NEW APPLICATION PROCESSING
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with AXOSINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thomas M. Saunders
Thomas M. Saunders Seyfarth Shaw LLPTwo Seaport LaneSuite 300Boston, MA 02110-2028Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | For therapeutic agents, namely for treatment of stroke and CNS inflammation, reducing penumbral stroke damage and for shrinking neural tissue, including inosine containing compositions for infusion including infusion ito cerebral spinal fluid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 1, 2007 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 19, 2005 | MAB1 | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | — |
| Jan 19, 2005 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Jan 18, 2005 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Jan 12, 2005 | PAPER RECEIVED | — | |
| Aug 5, 2004 | NWAP | NEW APPLICATION ENTERED | — |